Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Rebecca Perrett.
Newcastle Authors
Title
Year
Full text
Professor Ruth Plummer
Rebecca Perrett
Professor Alan Calvert
A phase I and pharmacokinetic (PK) study of BIBW 2992, an oral irreversible dual EGFR/HER2 inhibitor
2007
Professor Alan Calvert
Dr Fathi Azribi
Rebecca Perrett
Professor Ruth Plummer
Activity of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, in non-small cell lung cancer (NSCLC) with mutated EGFR
2007
Dr Graham Dark
Rebecca Perrett
Deconstructing the construction of a learning module on practice development
2007
Professor Ruth Plummer
Dr Louise Li
Rebecca Perrett
Professor Alan Calvert
Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers
2007
Dr Graham Dark
Rebecca Perrett
Practice development - Part 1: Developing a practice initiative in oncology and palliative care
2007
Dr Graham Dark
Rebecca Perrett
Practice development - Part 2: evaluating a practice initiative
2007
Dr Graham Dark
Rebecca Perrett
Using e-learning as a tool for multidisciplinary education
2007
Professor Ruth Plummer
Rebecca Perrett
Professor Alan Calvert
A phase I dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in patients with advanced solid tumours
2006
Professor Ruth Plummer
Dr Louise Li
Rebecca Perrett
Professor Alan Calvert
Phase I study of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, showing activity in tumours with mutated EGFR
2006
Professor Ruth Plummer
Rebecca Perrett
Professor Alan Calvert
A phase 1 dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in a continuous schedule in patients with advanced solid tumors
2005